Consequences of oral antithrombotic use in patients with chronic kidney disease

Consequences of oral antithrombotic use in patients with chronic kidney disease

Abstract We assessed the risks of bleeding, acute kidney injury (AKI), and kidney failure associated with the prescription of antithrombotic agents (oral anticoagulants and/or antiplatelet agents) in patients with moderate‐to‐advanced chronic kidney disease (CKD). CKD‐REIN is a prospective cohort of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Solène M. Laville, Oriane Lambert, Aghiles Hamroun, Marie Metzger, Christian Jacquelinet, Maurice Laville, Luc Frimat, Denis Fouque, Christian Combe, Carole Ayav, Roberto Pecoits‐Filho, Bénédicte Stengel, Ziad A. Massy, Sophie Liabeuf, the CKD‐REIN Study Collaborators
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
Therapeutics. Pharmacology
RM1-950
Public aspects of medicine
RA1-1270
Accès en ligne:https://doaj.org/article/496f063a74864d888537bfc7d12c9f05
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/496f063a74864d888537bfc7d12c9f05

Documents similaires